From Lived Experience to Evidence | AI-Driven Social Media Listening, Predictors, and Everyday Outcomes in Blood Cancers

From Lived Experience to Evidence | AI-Driven Social Media Listening, Predictors, and Everyday Outcomes in Blood Cancers

by alfie | Sep 18, 2025 | featured, news and press

< Back to Sanius content From Lived Experience to Evidence | AI-Driven Social Media Listening, Predictors, and Everyday Outcomes in Blood Cancers With September dedicated to recognising the impact of research, studies, science, patients, carers, patient...
HPCC26 × CRF26 | Sir Jim Mackey to headline europe’s largest patient-centred rare disease, haemato-oncology, research and innovation congress

HPCC26 × CRF26 | Sir Jim Mackey to headline europe’s largest patient-centred rare disease, haemato-oncology, research and innovation congress

by alfie | Sep 15, 2025 | featured, news and press

< Back to Sanius content HPCC26 × CRF26 | Sir Jim Mackey to headline europe’s largest patient-centred rare disease, haemato-oncology, research and innovation congress Now entering its third year, the Haematology Patient & Carers Congress (HPCC26) and the...
Transforming Chronic Myeloid Leukaemia Outcomes | Digital Health, Patient Empowerment, and Real-World Evidence

Transforming Chronic Myeloid Leukaemia Outcomes | Digital Health, Patient Empowerment, and Real-World Evidence

by alfie | Sep 15, 2025 | featured, news and press

< Back to Sanius content Transforming Chronic Myeloid Leukaemia Outcomes | Digital Health, Patient Empowerment, and Real-World Evidence Chronic Myeloid Leukaemia (CML) is often seen as one of the great success stories in rare disease, but the next chapter is only...
Advancing Multiple Myeloma Care | Building the Future of Patient Outcomes, Research, and Support

Advancing Multiple Myeloma Care | Building the Future of Patient Outcomes, Research, and Support

by alfie | Sep 15, 2025 | featured, news and press

< Back to Sanius content Advancing Multiple Myeloma Care | Building the Future of Patient Outcomes, Research, and Support Multiple Myeloma (MM) has seen rapid innovation over the past decade. New therapies are extending survival, reshaping treatment pathways, and...
Wearable Tech in the NHS’s Next Phase of Healthcare Outcomes Acceleration | Supporting Patients with Rare and Chronic Conditions.

Wearable Tech in the NHS’s Next Phase of Healthcare Outcomes Acceleration | Supporting Patients with Rare and Chronic Conditions.

by alfie | Sep 15, 2025 | featured, news and press

< Back to Sanius content Wearable Tech in the NHS’s Next Phase of Healthcare Outcomes Acceleration | Supporting Patients with Rare and Chronic Conditions. Sanius Health is excited about the recent developments from the NHS regarding better access for patients to...
« Older Entries